Literature DB >> 2148156

The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity.

R Huber1, M Schneider, I Mayr, J Römisch, E P Paques.   

Abstract

Crystal structure analysis and refinement at 2.0 A resolution of a rhombohedral crystal form of human annexin V at high calcium concentration revealed a domain motion compared to the previously analysed hexagonal crystal form. Five calcium ions were located on the convex face of the molecule. Three strongly bound calciums are liganded at protruding interhelical loops and Asp or Glu residues in homologous positions in repeats I, II and IV. Five proteinaceous oxygens and one solvent molecule form the coordination polyhedron in each case. The unoccupied seventh site is suggested as the phospholipid headgroup binding site. Two more weakly bound sites were identified by lanthanum labelling. The structural features suggest that annexin V attaches with its convex face to membranes by specific calcium mediated interactions with at least three phospholipids. The adjacent membrane bilayer may thus become locally disordered and permeable to allow calcium inflow through the central polar channel of the molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148156     DOI: 10.1016/0014-5793(90)81428-q

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

1.  Inositol polyphosphate receptor and clathrin assembly protein AP-2 are related proteins that form potassium-selective ion channels in planar lipid bilayers.

Authors:  A P Timerman; M M Mayrleitner; T J Lukas; C C Chadwick; A Saito; D M Watterson; H Schindler; S Fleischer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 2.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

3.  Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.

Authors:  Lisette Ungethüm; Heidi Kenis; Gerry A Nicolaes; Ludovic Autin; Svetla Stoilova-McPhie; Chris P M Reutelingsperger
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

4.  Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Authors:  Cheng-Yeu Wu; Jan Martel; Wei-Yun Cheng; Chao-Chih He; David M Ojcius; John D Young
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

5.  cDNA isolation and gene expression of the maize annexins p33 and p35.

Authors:  N H Battey; N C James; A J Greenland
Journal:  Plant Physiol       Date:  1996-11       Impact factor: 8.340

6.  Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: implications for annexin-induced membrane aggregation.

Authors:  Nien-Jen Hu; Jeremy Bradshaw; Hans Lauter; Julia Buckingham; Egle Solito; Andreas Hofmann
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

Review 7.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 8.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

9.  Isolation, characterization and localization of annexin V from chicken liver.

Authors:  C M Boustead; R Brown; J H Walker
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

Review 10.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.